HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephanie L Sherman Selected Research

5' Untranslated Regions (5' UTR)

11/2017Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.
1/2014Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI).
1/2014Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.
12/2012Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
7/2010Genetic diversity of the fragile X syndrome gene (FMR1) in a large Sub-Saharan West African population.
12/2008No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50.
9/2008Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.
1/2008Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
4/2004A study of the distributional characteristics of FMR1 transcript levels in 238 individuals.
2/2003Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephanie L Sherman Research Topics

Disease

9Down Syndrome (Down's Syndrome)
07/2021 - 11/2004
8Intellectual Disability (Idiocy)
12/2012 - 06/2002
5Primary Ovarian Insufficiency
11/2017 - 11/2011
5Fragile X Syndrome (Martin Bell Syndrome)
12/2012 - 06/2002
3Congenital Abnormalities (Deformity)
03/2013 - 09/2010
3Congenital Heart Defects (Congenital Heart Defect)
06/2012 - 09/2010
2Fragile X Tremor Ataxia Syndrome
12/2022 - 01/2022
2COVID-19
03/2022 - 08/2021
2Infertility (Sterility)
01/2018 - 01/2014
2Atrioventricular Septal Defect
10/2012 - 09/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022
1Breakthrough Infections
03/2022
1Pneumonia (Pneumonitis)
08/2021
1Human Influenza (Influenza)
10/2019
1Amenorrhea
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1Seizures (Absence Seizure)
06/2017
1Atrial Heart Septal Defects (Atrial Septal Defect)
10/2011
1Neural Tube Defects (Exencephaly)
10/2011
1Klinefelter Syndrome (Klinefelter's Syndrome)
10/2009
1Trisomy (Trisomies)
12/2008
1X-Linked Mental Retardation (Mental Retardation, X Linked)
06/2002

Drug/Important Bio-Agent (IBA)

115' Untranslated Regions (5' UTR)IBA
11/2017 - 06/2002
5DNA (Deoxyribonucleic Acid)IBA
12/2012 - 11/2004
3Folic Acid (Vitamin M)FDA LinkGeneric
03/2013 - 09/2010
2RNA (Ribonucleic Acid)IBA
01/2022 - 12/2012
2Estrogens (Estrogen)FDA Link
01/2018 - 01/2014
1CytosineIBA
12/2022
1GuanineIBA
12/2022
1VaccinesIBA
03/2022
1COVID-19 VaccinesIBA
03/2022
1Hormones (Hormone)IBA
01/2018
1Antipsychotic Agents (Antipsychotics)IBA
06/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012
1Biological ProductsIBA
06/2012
1UbiquitinIBA
11/2011
1Oxidoreductases (Dehydrogenase)IBA
09/2010
15-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA
09/2010
1methionine synthase reductaseIBA
09/2010
1Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
09/2010
1Reduced Folate Carrier ProteinIBA
09/2010
1AmelogeninIBA
10/2009

Therapy/Procedure

1Length of Stay
08/2021
1Therapeutics
07/2021
1Dental Care
10/2019
1Hysterectomy
01/2018